drugset / Trial / NCT00560599

A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection

NCT00560599

Phase 3 Completed 350 enrolled loren g miller Kaiser Permanente · collab
RandomizedFactorialOpen-labelPrevention

Summary

This clinical trial tests the hypotheses that 1) body decolonization of patients with recurrent community-associated (CA) MRSA infections and their household members and 2) environmental decolonization of the patients' households will significantly reduce the likelihood of recurrent CA-MRSA infection.

Timeline

Start
2007-04
Primary completion
2012-02
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine Small molecule Topical
Subject Mupirocin Small molecule Intranasal